Researchers say a new drug may be a breakthrough in the treatment of Hodgkin's Lymphoma. According to the study, published in the New England Journal of Medicine , the drug Nivolumab could be an effective means of treating the cancer in patients whose disease does not respond to chemotherapy or stem cell transplants.
http://ift.tt/1q8eDBF
http://ift.tt/1q8eDBF
No comments:
Post a Comment